STOCKS | Elanco Rises Nearly 8% After Q3 Earnings Beat, Outlook Increase

Elanco Animal Health shares rose nearly 8% after third-quarter earnings topped expectations and the company raised its full-year outlook, according to Bloomberg. CEO Jeff Simmons called it a high-quality quarter, citing 11% reported growth and broad strength across markets and product lines during an interview on “The Close.”